Elizabeth M. Jaffee, MD, AACR President, and Elaine R. Mardis, PhD, President-Elect for 2018-2019
Head and neck cancers account for nearly 3 percent of all cancers in the United States, the National Cancer Institute reported.
Abstract Deadline: April 30Sharing the latest and most exciting developments in lung cancer research
Stand Up To Cancer takes new approach to multiple myeloma, focusing on precursor conditions
Read AACR journal articles related to the major topics presented in the 2018 Annual Meeting sessions.
Application Deadline: May 4A three-year grant of $225,000 for projects focusing on DNA Damage Response pathways.
TLR9 Agonist CMP-001-Pembrolizumab Combination Shows Early Efficacy in Patients With Metastatic Melanoma Resistant to Anti-PD-1
Dual Inhibition of IDO1 and PD-L1 Safe in Patients With Advanced Solid Tumors
Short-acting Calcium Channel Blockers Were Associated With Increased Risk of Pancreatic Cancer in Postmenopausal Women
Latest Advances in Lung Cancer Research
Advances in Malignant Lymphoma
AACR-Johnson & Johnson Lung Cancer Innovation Science Grants
Cancer Dormancy and Residual Disease